Maintenance therapy for inflammatory bowel disease: What really works

Canadian Journal of Gastroenterology

Volumn 11, Issue 3, 1997, Pages 261-264

  Sutherland, Lloyd R ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Inflammatory bowel disease; Maintenance therapy; Patient quality of life; Review; Therapy

Indexed keywords

AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; MESALAZINE; SALAZOSULFAPYRIDINE; TOBRAMYCIN;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; MORBIDITY; NUTRITIONAL HEALTH; PRIORITY JOURNAL; QUALITY OF LIFE; REMISSION; SHORT SURVEY; ULCERATIVE COLITIS;

EID: 0030903812     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/1997/359020     Document Type: Short Survey

References (12)

1. Edwards F, Truelove SC. The course and prognosis of ulcerative colitis 1. Short-term prognosis. Gut 1963;4:299-308.
2. Edwards F, Truelove SC. The course and prognosis of ulcerative colitis II. Long-term prognosis. Gut 1963;4:309-15.
3. Kornbluth AA, Salomon P, Sacks HS, Mitty R, Janowitz HD. Meta-analysis of the effectiveness of current drug therapy of ulcerative colitis. J Clin Gastroenterol 1993;16:215-8.
4. Azad Khan AK, Piris J, Truelove SC, Howes DT. An optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis. Gut 1980;21:232-40.
5. Miner P, Schwartz J, Aora S, et al. Maintenance of remission in ulcerative colitis (UC) patients with controlled-release mesalamine capsules (Pentasa). Gastroenterology 1992;102:A666. (Abst)
6. Hanauer S, Powers B, Robinson M, et al. Maintenance of remission of ulcerative colitis by mesalamine (Asacol) vs placebo. Gastroenterology 1994;106:A696. (Abst)
7. Wright JP, O'Keefe EA, Cuming L, Jaskiewicz K. Olsalazine in maintenance of clinical remission in patients with ulcerative colitis. Dig Dis Sci 1993;38:1837-42.
8. Sutherland LR, May GR, Shaffer EA. Sulfasalazine revisited: A meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis. Ann Intern Med 1993;118:540-9.
9. Kjærgaard N, Ambrosius Christensen L, Lauritsen JG, Norby Rasmussen S, Honoré Hansen S. Effects of mesalazine substitution on salicylazo-sulfapyridine-induced seminal abnormalities in men with ulcerative colitis. Scand J Gastroenterol 1989;24:891-6.
10. Truelove SC, Witts LJ. Cortisone and corticotrophin in ulcerative colitis. BMJ 1959;i:387-94.
11. Lennard-Jones JE, Misiewicz JJ, Connell AM, Baron JH, Jones FA. Prednisone as maintenance treatment for ulcerative colitis in remission. Lancet 1965;i:188-9.
12. Powell-Tuck J, Parkins RA. A controlled trial of alternate day prednisolone as a maintenance treatment for ulcerative colitis in remission. Digestion 1981;22:263-70.